Pharmacogenomics of breast cancer therapy: An updateWESTBROOK, Kelly; STEARNS, Vered.Pharmacology & therapeutics (Oxford). 2013, Vol 139, Num 1, pp 1-11, issn 0163-7258, 11 p.Article

Personalized Tamoxifen: A Step Closer but Miles To GoBARDIA, Aditya; STEARNS, Vered.Clinical cancer research (Print). 2010, Vol 16, Num 17, pp 4308-4310, issn 1078-0432, 3 p.Article

Effect of simvastatin on the pharmacokinetics of anastrozoleTING BAO; BLACKFORD, Amanda L; STEARNS, Vered et al.Breast cancer research and treatment. 2012, Vol 131, Num 2, pp 709-711, issn 0167-6806, 3 p.Article

Epigenetics as a Therapeutic Target in Breast CancerCONNOLLY, Roisin; STEARNS, Vered.Journal of mammary gland biology and neoplasia. 2012, Vol 17, Num 3-4, pp 191-204, issn 1083-3021, 14 p.Article

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancerYAMAUCHI, Hideko; STEARNS, Vered; HAYES, Daniel F et al.Journal of clinical oncology. 2001, Vol 19, Num 8, pp 2334-2356, issn 0732-183XArticle

Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trialSTEARNS, Vered; BEEBE, Katherine L; IYENGAR, Malini et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 21, pp 2827-2834, issn 0098-7484, 8 p.Article

New prognostic factors for breast cancer recurrenceISAACS, Claudine; STEARNS, Vered; HAYES, Daniel F et al.Seminars in oncology. 2001, Vol 28, Num 1, pp 53-67, issn 0093-7754Article

Epigenetic Regulation in Estrogen Receptor Positive Breast Cancer: Role in Treatment ResponsePATHIRAJA, Thushangi N; STEARNS, Vered; OESTERREICH, Steffi et al.Journal of mammary gland biology and neoplasia. 2010, Vol 15, Num 1, pp 35-47, issn 1083-3021, 13 p.Article

Drug Interactions and Pharmacogenomics in the Treatment of Breast Cancer and DepressionHENRY, N. Lynn; STEARNS, Vered; FLOCKHART, David A et al.The American journal of psychiatry. 2008, Vol 165, Num 10, pp 1251-1255, issn 0002-953X, 5 p.Article

Hot flushesSTEARNS, Vered; ULLMER, Lynda; LOPEZ, Juan F et al.Lancet (British edition). 2002, Vol 360, Num 9348, pp 1851-1861, issn 0140-6736, 11 p.Article

A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitorsTING BAO; LING CAI; ARMSTRONG, Deborah K et al.Breast cancer research and treatment. 2013, Vol 138, Num 1, pp 167-174, issn 0167-6806, 8 p.Article

Phase II Trial of Bicalutamide in Patients with Androgen Receptor―Positive, Estrogen Receptor―Negative Metastatic Breast CancerGUCALP, Ayca; TOLANEY, Sara; STEARNS, Vered et al.Clinical cancer research (Print). 2013, Vol 19, Num 19, pp 5505-5512, issn 1078-0432, 8 p.Article

Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast CancerSTEARNS, Vered; JACOBS, Lisa K; POWERS, Penny et al.Clinical cancer research (Print). 2013, Vol 19, Num 14, pp 4008-4016, issn 1078-0432, 9 p.Article

A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerHIGGINS, Michaela J; PROWELL, Tatiana M; FETTING, John H et al.Breast cancer research and treatment. 2012, Vol 131, Num 3, pp 915-924, issn 0167-6806, 10 p.Article

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive ²³Na MRIOUWERKERK, Ronald; JACOBS, Michael A; MACURA, Katarzyna J et al.Breast cancer research and treatment. 2007, Vol 106, Num 2, pp 151-160, issn 0167-6806, 10 p.Article

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatmentYAN JIN; DESTA, Zeruesenay; BLANCHARD, Rebecca et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 1, pp 30-39, issn 0027-8874, 10 p.Article

Prognostic factors in breast cancer: Current and new predictors of metastasisHAYES, Daniel F; ISAACS, Claudine; STEARNS, Vered et al.Journal of mammary gland biology and neoplasia. 2001, Vol 6, Num 4, pp 375-392, issn 1083-3021Article

Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerRUDEK, Michelle A; CONNOLLY, Roisin M; WATKINS, Stanley P et al.Breast cancer research and treatment. 2013, Vol 139, Num 1, pp 135-143, issn 0167-6806, 9 p.Article

A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasiaSTEARNS, Vered; COOP, Andrew; SINGH, Baljit et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7583-7591, issn 1078-0432, 9 p.Article

Development and validation of a method for using breast core needle biopsies for Gene expression microarray analysesELLIS, Matthew; DAVIS, Natalie; STEARNS, Vered et al.Clinical cancer research. 2002, Vol 8, Num 5, pp 1155-1166, issn 1078-0432Article

CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer PatientsRAE, James M; DRURY, Suzy; HAYES, Daniel F et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 6, pp 452-460, issn 0027-8874, 9 p.Article

Race and Hormone Receptor-Positive Breast Cancer Outcomes in a Randomized Chemotherapy TrialSPARANO, Joseph A; MOLIN WANG; WOOD, William C et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 5, pp 406-414, issn 0027-8874, 9 p.Article

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortHENRY, N. Lynn; RAE, James M; HAYES, Daniel F et al.Breast cancer research and treatment. 2009, Vol 117, Num 3, pp 571-575, issn 0167-6806, 5 p.Article

Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer SurvivorsELKINS, Gary; MARCUS, Joel; STEARNS, Vered et al.Journal of clinical oncology. 2008, Vol 26, Num 31, pp 5022-5026, issn 0732-183X, 5 p.Article

A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in Women at high risk with biomarkers as surrogate endpoints for activitySTEARNS, Vered; GALLAGHER, Ann; TROCK, Bruce et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8332-8340, issn 1078-0432, 9 p.Article